A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles

Kingsley, 2006, Nanotechnology: a focus on nanoparticles as a drug delivery system, J. Neuroimmune. Pharmacol., 1, 340, 10.1007/s11481-006-9032-4 Pridgen, 2007, Biodegradable, polymeric nanoparticle delivery systems for cancer therapy, Nanomed, 2, 669, 10.2217/17435889.2.5.669 Soppimath, 2001, Biodegradable polymeric nanoparticles as drug delivery devices, J. Control. Release, 70, 1, 10.1016/S0168-3659(00)00339-4 Fessi, 1992, U.S. patent, 5, 528 Vanderhoff, 1979, Polymer emulsification process, U.S. Pat., 4, 177 Niwa, 1993, Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with d,l-lactide glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior, J. Control. Release, 25, 89, 10.1016/0168-3659(93)90097-O Quintanar-Guerrero, 1999, Pseudolatex preparation using a novel emulsion-diffusion process involving direct displacement of partially water-miscible solvents by distillation, Int. J. Pharm., 188, 155, 10.1016/S0378-5173(99)00216-1 Ogawa, 1988, A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid, Chem. Pharm. Bull. (Tokyo)., 36, 1095, 10.1248/cpb.36.1095 Zambaux, 1998, Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method, J. Control. Release, 50, 31, 10.1016/S0168-3659(97)00106-5 Quintanar-Guerrero, 1998, Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers, Drug Dev. Ind. Pharm., 24, 1113, 10.3109/03639049809108571 Tewes, 2007, Comparative study of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods, Eur. J. Pharm. Biopharm., 66, 488, 10.1016/j.ejpb.2007.02.016 Chorny, 2002, Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulation variables on size, drug recovery and release kinetics, J. Control. Release, 83, 389, 10.1016/S0168-3659(02)00211-0 Gorner, 1999, Lidocaine-loaded biodegradable nanospheres. I. Optimization of the drug incorporation into the polymer matrix, J. Control. Release, 57, 259, 10.1016/S0168-3659(98)00121-7 Govender, 1999, PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug, J. Control. Release, 57, 171, 10.1016/S0168-3659(98)00116-3 Cohen-Sela, 2006, Nanospheres of a bisphosphonate attenuate intimal hyperplasia, J. Nanosci. Nanotechnol., 6, 3226, 10.1166/jnn.2006.428 Danenberg, 2003, Liposomal alendronate inhibits systemic innate immunity and reduces in-stent neointimal hyperplasia in rabbits, Circulation, 108, 2798, 10.1161/01.CIR.0000097002.69209.CD Danenberg, 2002, Macrophage depletion by clodronate-containing liposomes reduces neointimal formation after balloon injury in rats and rabbits, Circulation, 106, 599, 10.1161/01.CIR.0000023532.98469.48 Golomb, 1996, Controlled delivery of a tyrphostin inhibits intimal hyperplasia in a rat carotid artery injury model, Atherosclerosis, 125, 171, 10.1016/0021-9150(96)05868-6 Fishbein, 2000, Local delivery of platelet-derived growth factor receptor-specific tyrphostin inhibits neointimal formation in rats, Arterioscler. Thromb. Vasc. Biol., 20, 667, 10.1161/01.ATV.20.3.667 Barichello, 1999, Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method, Drug Dev. Ind. Pharm., 25, 471, 10.1081/DDC-100102197 Budhian, 2007, Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content, Int. J. Pharm., 336, 367, 10.1016/j.ijpharm.2006.11.061 Quintanar-Guerrero, 1997, A mechanistic study of the formation of polymer nanoparticles by the emulsification-diffusion technique, Colloid Polym. Sci., 275, 640, 10.1007/s003960050130 Kreuter, 1991, nanoparticle-based drug delivery systems, J. Control. Release, 16, 169, 10.1016/0168-3659(91)90040-K Storm, 1995, Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system, Adv. Drug. Deliv. Rev., 17, 31, 10.1016/0169-409X(95)00039-A Cohen-Sela, 2006, Alendronate-loaded nanoparticles deplete monocytes and attenuate restenosis, J. Control. Release, 113, 23, 10.1016/j.jconrel.2006.03.010 Athanasiou, 1996, Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid polyglycolic acid copolymers, Biomaterials, 17, 93, 10.1016/0142-9612(96)85754-1 Volland, 1994, The influence of terminal gamma-sterilization on captopril containing poly(D,L-lactide-co-glycolide) microspheres, J. Control. Release, 31, 293, 10.1016/0168-3659(94)90012-4 Hausberger, 1995, Gamma-irradiation effects on molecular-weight and in-vitro degradation of poly(d,l-lactide-co-glycolide) microparticles, Pharma. Res., 12, 851, 10.1023/A:1016256903322 Leo, 2004, In vitro evaluation of PLA nanoparticles containing a lipophilic drug in water-soluble or insoluble form, Int. J. Pharm., 278, 133, 10.1016/j.ijpharm.2004.03.002 Golomb, 1986, Inhibition of bioprosthetic heart valve calcification by sustained local delivery of Ca and Na diphosphonate via controlled release matrices, ASAIO Trans., 32, 587, 10.1097/00002480-198609000-00045